During the past decade, West Virginia University - Robert C. Byrd Health Sciences Center - Charleston Division conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "West Virginia University - Robert C. Byrd Health Sciences Center - Charleston Division" #1 sponsor was "Children's Oncology Group" with 22 trials, followed by "Eastern Cooperative Oncology Group" with 7 trials sponsored, "Alliance for Clinical Trials in Oncology" with 2 trials sponsored, "Amgen" with 2 trials sponsored and "Novartis Pharmaceuticals" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "West Virginia University - Robert C. Byrd Health Sciences Center - Charleston Division" #1 collaborator was "National Cancer Institute (NCI)" with 32 trials as a collaborator, "SWOG Cancer Research Network" with 2 trials as a collaborator, "American College of Surgeons" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "NCIC Clinical Trials Group" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "West Virginia University - Robert C. Byrd Health Sciences Center - Charleston Division" are "Leukemia" (9 trials), "Sarcoma" (5 trials), "Kidney Cancer" (3 trials), "Lung Cancer" (3 trials) and "Myelodysplastic Syndromes" (3 trials). Many other conditions were trialed in "West Virginia University - Robert C. Byrd Health Sciences Center - Charleston Division" in a lesser frequency.

Most popular intervention types in "West Virginia University - Robert C. Byrd Health Sciences Center - Charleston Division" are "Drug" (35 trials), "Biological" (15 trials), "Radiation" (14 trials), "Procedure" (9 trials) and "Genetic" (2 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (14 trials), "filgrastim" (12 trials), "radiation therapy" (12 trials), "vincristine sulfate" (9 trials) and "etoposide" (8 trials). Other intervention names were less common.

The vast majority of trials in "West Virginia University - Robert C. Byrd Health Sciences Center - Charleston Division" are 40 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "West Virginia University - Robert C. Byrd Health Sciences Center - Charleston Division". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 36 completed trials in West Virginia University - Robert C. Byrd Health Sciences Center - Charleston Division, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in West Virginia University - Robert C. Byrd Health Sciences Center - Charleston Division, 4 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".